08 August 2025
08 August 2025
Eli Lilly reported $15.56bn in revenue, driven by its weight loss and diabetes drugs, intensifying pressure on rival Novo Nordisk.
The acquisition entails royalties from US net sales of both Rezzayo and Minocin.
The FDA completed a benefit-risk revaluation following two deaths in the French territory of La 搁茅耻苍颈辞苍.
While Epkinly is approved in third-line follicle lymphoma, its success in the second-line setting is pertinent.
MAX-001 provides both rapid onset and extended duration of analgesia.
Bayer disclosed that its Q2 earnings were inflated by transfer fees at its German football club Bayer Leverkusen.
The health secretary has halted the development of 22 mRNA vaccine projects by BARDA while stopping all future schemes.
Merging industry-leading business intelligence & award-winning journalism, this is an unrivalled opportunity for engagement with B2B professionals across a network of 40+ leading media websites.
Steer your business strategy with key data and insights from our latest market research reports and company profiles. Not ready to buy? Start small by downloading a sample report first.
Give your business an edge with our leading industry insights.
